BIOSTROPHIN
Dead / Cancelled — Cancelled — Section 8 (as of 07 Nov 2014)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78683525
- Registration number
- 3406791
- Mark type
- Stylized text
- Filed
- 02 Aug 2005
- Published for opposition
- 19 Sept 2006
- Registered
- 01 Apr 2008
- Attorney of record
- Vanessa Hamilton Anderson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, a therapeutic treatment for duchenne's muscular dystrophy
Owner
- Asklepios Biopharmaceutical, Inc., Chapel Hill, NC, US
- Asklepios Biopharmaceutical, Inc., Chapel Hill, NC, US
- Asklepios Biopharmaceutical, Inc., Chapel Hill, NC, US
Prosecution history
- 07 Nov 2014 — CANCELLED SEC. 8 (6-YR)
- 01 Apr 2008 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2008 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 23 Feb 2008 — ASSIGNED TO LIE
- 24 Jan 2008 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Jan 2008 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jan 2008 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jan 2008 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 19 Sept 2007 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 19 Sept 2007 — FINAL REFUSAL E-MAILED
- 19 Sept 2007 — SU - FINAL REFUSAL - WRITTEN
- 08 Sept 2007 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Aug 2007 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Aug 2007 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Jul 2007 — NOTIFICATION OF NON-FINAL ACTION E-MAILED